ACW.AX
Price:
$0.025
Market Cap:
$78.32M
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.[Read more]
Industry
Biotechnology
IPO Date
2007-10-16
Stock Exchange
ASX
Ticker
ACW.AX
According to Actinogen Medical Limited’s latest financial reports and current stock price. The company's current ROE is -82.36%. This represents a change of 88.23% compared to the average of -43.76% of the last 4 quarters.
The mean historical ROE of Actinogen Medical Limited over the last ten years is -46.01%. The current -82.36% ROE has changed 79.01% with respect to the historical average. Over the past ten years (40 quarters), ACW.AX's ROE was at its highest in in the September 2012 quarter at 8.61%. The ROE was at its lowest in in the June 2012 quarter at -110.17%.
Average
-46.01%
Median
-39.89%
Minimum
-80.20%
Maximum
-22.43%
Discovering the peaks and valleys of Actinogen Medical Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 94.81%
Maximum Annual ROE = -22.43%
Minimum Annual Increase = -54.19%
Minimum Annual ROE = -80.20%
Year | ROE | Change |
---|---|---|
2024 | -66.23% | -17.42% |
2023 | -80.20% | 83.58% |
2022 | -43.69% | 94.81% |
2021 | -22.43% | -54.19% |
2020 | -48.96% | -22.44% |
2019 | -63.12% | 74.84% |
2018 | -36.10% | 5.99% |
2017 | -34.06% | 13.67% |
2016 | -29.97% | -15.26% |
2015 | -35.37% | -2.65% |
The current ROE of Actinogen Medical Limited (ACW.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-63.37%
5-year avg
-52.30%
10-year avg
-46.01%
Actinogen Medical Limited’s ROE is greater than Imugene Limited (-95.62%), greater than AnteoTech Limited (-176.60%), less than Antisense Therapeutics Limited (0%), greater than Prescient Therapeutics Limited (-40.50%), greater than Biotron Limited (-423.05%),
Company | ROE | Market cap |
---|---|---|
-95.62% | $319.85M | |
-176.60% | $51.40M | |
0% | $52.29M | |
-40.50% | $38.66M | |
-423.05% | $15.34M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actinogen Medical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Actinogen Medical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Actinogen Medical Limited's ROE?
How is the ROE calculated for Actinogen Medical Limited (ACW.AX)?
What is the highest ROE for Actinogen Medical Limited (ACW.AX)?
What is the 3-year average ROE for Actinogen Medical Limited (ACW.AX)?
What is the 5-year average ROE for Actinogen Medical Limited (ACW.AX)?
How does the current ROE for Actinogen Medical Limited (ACW.AX) compare to its historical average?